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a b s t r a c t
Background: Some studies have shown a higher occurrence of unfavorable lipid proﬁle in
women with migraine as compared to the general population.
Aim: The aim of our study was to assess the link between lipid proﬁle and the frequency of
migraine attacks.
Patients and methods: 64 female migraine patients, mean age 40  10.84 years and mean
duration of the disease 18.52  7.57 years, were included into the study. Lipid proﬁle (total
cholesterol, TC; low-density lipoprotein cholesterol, LDL-C; high-density lipoprotein cho-
lesterol, HDL-C; triglycerides, TG) was evaluated in all migraine patients. Frequency of
migraine attacks was calculated from the amount of migraine episodes within the last
3 months.
Results: The correlation between TC and TG and the frequency of the migraine attacks were
statistically signiﬁcant.
Conclusion: TC and TG values may have an inﬂuence on migraine severity and also contrib-
ute to the increased risk of cardiovascular diseases, especially in women.
# 2015 Polish Neurological Society. Published by Elsevier Sp. z o.o. All rights reserved.
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In some populations high level of cholesterol may affect even
more that 50% of the cases [1–5]. The major problem with a
proper diagnosis of dyslipidemia is its asymptomatic course
which ﬁnally leads to the development of severe and
irreversible conditions of cardiovascular nature. Not to
mention that the ﬁnal effect of elevated lipid levels may be
massive and destructive stroke, heart attack and eventually* Corresponding author at: Department of Neurology, Medical Universit
fax: +48 22 599 18 57.
E-mail address: izabela.domitrz@wum.edu.pl (I. Domitrz).
http://dx.doi.org/10.1016/j.pjnns.2015.02.001
0028-3843/# 2015 Polish Neurological Society. Published by Elsevier Sdeath [6–8]. Some recent studies showed that prevalence of
migraine and its severity might be related to serum level of
lipids. Most of them postulated that an abnormal lipid proﬁle
may be linked with greater odds of migraine [9–13]. Although
Monastero et al. did not ﬁnd any correlation between
abnormal cholesterol level and frequency of migraine episodes
[12]. Also migraine is reported to increase the risk of
cardiovascular events like stroke, atherosclerosis and perhaps
coronary heart disease [14–17]. Such ﬁnding combined with
abnormal lipid proﬁle might multiply cardiovascular risk iny, 1a Banacha Street, 02-097 Warsaw, Poland. Tel.: +48 22 599 28 57;
p. z o.o. All rights reserved.
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mentioned hypotheses the aim of our study was to evaluate
the serum level of total cholesterol (TC), low-density lipopro-
tein cholesterol (LDL-C), high-density lipoprotein cholesterol
(HDL-C) or triglycerides (TG) in migraine patients as a factor
which might play a role in a more often manifestation of
migraine episodes.
2. Patients and methods
Our study is a cross-sectional study performed in the
Headache Outpatient Clinic of Department of Neurology
Warsaw Medical University. Consecutive migraine patients
were examined in the Headache Outpatient Clinic from
November 2010 to April 2012.
71 migraine patients were included into the study. Patients
with a known history of metabolic, cardiovascular or other
diseases were excluded from study. Our study group did not
included individuals on medications affecting cholesterol and
triglycerides levels. The study group consisted of patients
without migraine prophylactic treatment. The study group
consisted of 64 women and 7 men, mean age 40  10.84 years.
The mean duration of the disease was 18.61  7.45 years, mean
frequency of migraine attacks 3.44  5.82 per month.
51 patients (72%) were diagnosed as patients with migraine
without aura and 20 (28%) patients had attacks of migraine
with aura. Migraine was diagnosed according to the Interna-
tional Headache Society (IHS) criteria, 2nd edition [18] and next
revised according to 3rd edition [19]. The full neurological
and general examination was performed. Frequency of the
migraine attacks was calculated from the number of migraine
episodes within the last 3 months. Our patients reported
the data using patient's diaries. Because of the small number
of our male patients, we ruled them out of the study to avoid
selection bias. Baseline characteristics of migraine patients are
presented in Table 1.
All patients had their blood samples tested during the ﬁrst
visit in the Headache Outpatient Clinic of the Neurology
Department. Our patients had lipid panel analysis for the ﬁrst
time. The value of 4 components (TC, HDL-C, LDL-C, TG) was




Age (years) 40  10.84
Duration of the migraine (years) 18.61  7.45
Frequency of migraine attacks
(attacks per month)
3.44  5.82
TC (mg/dl) 194.38  35.06
HDL-C (mg/dl) 66.4  13.86
LDL-C (mg/dl) 109  32.3
TG (mg/dl) 88.68  45.27
Migraine with aura (%) 28.17
TC, total cholesterol; LDL-C, low-density lipoprotein cholesterol;
HDL-C, high-density lipoprotein cholesterol; TG, triglycerides.enzymatic methods. Blood test was taken after a night of
fasting by venous puncture.
We assessed the association between lipid proﬁle values
and frequency of migraine attacks. The statistical analysis
was carried out using SAS 9.2 with Spearman correlation
coefﬁcients, which is nonparametric measure of statistical
dependence between two variables. P-values of <0.05
were considered statistically signiﬁcant. Lipid levels and
frequency of migraine episodes were treated as continuous
variables.
3. Results
The mean level of TC in migraine patients was 194.38
 35.06 mg/dl, mean LDL-C 109  32.3 mg/dl, mean HDL-C
66.4  13.86 mg/dl, mean triglycerides 88.68  45.27 mg/dl.
21 women (39%) had an increased TC level (>190 mg/dl),
18 (28%) had increased LDL-C (>115 mg/dl), 5 (8%) increased TG
level (>150 mg/dl) and 4 (6%) patients were diagnosed with
abnormally low HDL-C level (<50 mg/dl) (Table 2).
The statistical calculation revealed a signiﬁcant correlation
between a value of TC (p = 0.0481, r = 0.34) or TG ( p = 0.0147,
r = 0.41) and frequency of migraine attacks. Moreover, the
statistical analysis did not show any link between LDL-C
(p = 0.084, r = 0.31) or HDL-C ( p = 0.53, r = 0.11) level and
frequency of migraine. Statistical correlation between TC, TG,
HDL-C, LDL-C levels and frequency or duration of migraine is
presented in Fig. 1.
4. Discussion
We found the statistically signiﬁcant differences between the
value of TC, TG and frequency of migraine attacks. We found
only one published study making a similar comparison. Kurth
et al. did not ﬁnd any signiﬁcant link between TC, LDL-C and
HDL-C levels and frequency of migraine attacks. In this large
cross-sectional study all 27,626 female participants were over
45. Therefore, we cannot directly refer to such a speciﬁc
population [12]. The other studies mostly focused on abnormal
lipid levels and odds of migraine. Scher et al. in their GEM
population-based study concluded that migraineurs with aura
were more likely to have an abnormal cholesterol proﬁle. The
study group comprised 620 migraineurs (31% with aura and
64% without aura). The controls were 5135 probants without
any history of migraine. The odds of having an elevated
Framingham risk score for coronary heart disease wereTable 2 – The mean lipid values of the female population.
Migraine female patients
TC (>190 mg/dl) 21 (39%)
HDL-C (<50 mg/dl) 4 (6%)
LDL-C (>115 mg/dl) 18 (28%)
TG (>150 mg/dl) 5 (8%)
TC, total cholesterol; LDL-C, low-density lipoprotein cholesterol;
HDL-C, high-density lipoprotein cholesterol; TG, triglycerides.
Fig. 1 – Statistical correlation between TC, TG, HDL-C, LDL-C levels and frequency of migraine episodes a month (migraine
frequency) and migraine duration. TC, total cholesterol; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density
lipoprotein cholesterol; TG, triglycerides.
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[10]. Similarly Rist et al. stated that migraine with aura was
associated with a higher risk of cardiovascular diseases. Their
prospective study characterized 1155 probants aged 45 years
or older, 166 of who were the patients with migraine [13].
Manestro et al. showed that an elevated TC level was
signiﬁcantly associated with migraine in general. They
assessed the group of 1809 patients. 151 of them suffered
from migraine. The link between a TC level and migraine was
higher in elderly males with migraine [11]. Also the HUNT
study revealed a relationship between an unfavorable lipid
proﬁle and both types of migraine (with and without aura)
[17]. Gruber et al. study showed elevated oxidized LDL level
associated with a 7.93-fold higher risk for migraine [9]. The
results of some previous and our study concerning lipid levelsand migraine suggest a correlation between migraine and
abnormal lipid proﬁle.
It is worth to underline that the main strength of our study
is the ascertained method of the migraine diagnosis. The
types of the headache were not self-reported, so their
classiﬁcation was conﬁrmed by professionals. Our group
did not included individuals on drugs lowering cholesterol
and triglycerides levels. Neither they suffered from condi-
tions affecting lipid metabolism. In the other hand one of the
limitation of our study is a small number of the analyzed
group and also the lack of our own control group. Finally, we
did not carry out any adjustment of potential confounder,
such as age, tobacco smoking and the phenomenon of aura
which seems to worsen cardiovascular complications in
migraineurs [14,15].
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Our results show that migraine frequency might be associated
with TC and TG levels. The data suggests that migraine may
increase the risk of cardiovascular diseases, especially in
women. Higher level of TC and TG in migraine female patients
may multiply the risk of cardiovascular diseases.
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